ABSTRACT: Intervertebral disc degeneration is characterized by an imbalance between catabolic and anabolic signaling, with an increase in catabolic cytokines particularly IL-1b, a key regulator of IVD degeneration. This study aimed to investigate intracellular signaling pathways activated by IL-1b, and GDF-5 in the degenerate IVD to identify potential new therapeutic targets. Human NP cells were cultured in alginate beads to regain in vivo phenotype prior to stimulation with IL-1b or GDF-5 for 30 min, a proteasome profiler array was initially utilized to screen activation status of 46 signaling proteins. Immunoflourescence was used to investigate activation of the NFkB pathway. Cell-based ELISAs were then deployed to confirm results for ERK1/2, p38 MAPK, c-jun, and IkB signaling. IHC was utilized to investigate native activation status within human IVD tissue between grades of degeneration. Finally, cells were stimulated with IL-1b in the absence or presence of p38 MAPK, c-jun, JNK, and NFkB inhibitors to investigate effects on MMP3, MMP13, IL-1b, IL-6, and IL-8 mRNA expression. This study demonstrated three key signaling pathways which were differentially activated by IL-1b but not GDF-5; namely p38 MAPK, c-jun, and NFkB. While ERK 1/2 was activated by both GDF-5 and IL-1. Immunohistochemistry demonstrated p38 MAPK, c-jun, and NFkB were activated during human IVD degeneration and inhibition of these pathways reduced or abrogated the catabolic effects of IL-1b, with inhibition of NFkB signaling demonstrating most widespread inhibition of IL-1b catabolic effects. The intervertebral disc (IVD) is an important component of the spinal column enabling bending, flexion and torsion of the spine, composed of the cartilaginous end plates (CEP), the annulus fibrosus (AF), and the central gelatinous nucleus pulposus (NP). The major components are water, collagens, proteoglycans, non-collagenous proteins, and elastins. The collagen fibres of the IVD provide a strong durable framework supporting the cells and confine the highly hydrated proteoglycan aggregates.
The intervertebral disc (IVD) is an important component of the spinal column enabling bending, flexion and torsion of the spine, composed of the cartilaginous end plates (CEP), the annulus fibrosus (AF), and the central gelatinous nucleus pulposus (NP). The major components are water, collagens, proteoglycans, non-collagenous proteins, and elastins. The collagen fibres of the IVD provide a strong durable framework supporting the cells and confine the highly hydrated proteoglycan aggregates. 1 The normal human IVD contains chondrocyte-like cells within the NP and inner AF termed NP and AF cells, and fibroblast-like cells in the outer AF. These cells are responsible for the synthesis and regulation of the matrix in the disc and control the homeostasis between extracellular matrix (ECM) synthesis and ECM degradation. 2 Within the normal adult IVD, the anabolic and catabolic processes which regulate the ECM are thought to be kept in balance by a number of growth factors (e.g., TGF, FGF, IGF, GDF) and cytokines (e.g., IL-1, IL-6, IL-8, TNFa). [3] [4] [5] If this balance is disrupted in favor of catabolic processes, the IVD begins to degrade, resulting in disc degeneration which can lead to low back pain (LBP). 3 An improved understanding of the homeostatic mechanisms and those seen during degeneration of the disc are crucial to understanding the biology of this important tissue.
Increasing data suggest that inflammatory cytokines produced by NP cells within the IVD during degeneration are responsible for matrix degradation and induction of painful stimuli, [6] [7] [8] [9] [10] [11] [12] with a particular role for IL-1b hypothesized.
6,7,9-11 IL-1b has been shown to be increased in degenerate IVDs without a concordant increase in its antagonist (IL-1Ra). 6 IL-1b has also been shown to regulate a pleathora of events linked to IVD degeneration such as increased matrix degradation, decreased matrix synthesis, increased pro inflammatory cytokine production, and increased production of neurotrophic and angiogenic factors. [6] [7] [8] [9] [10] Spontaneous degeneration was seen in a mouse model where the natural inhibitor of IL-1b (IL-1Ra) was knocked out, 11 which together with increased risks of LBP in patients with IL-1b polymorphisms, [13] [14] [15] [16] suggests a major role for IL-1b in the pathogenesis of disc degeneration.
A number of methods to inhibit the catabolic processes (e.g., matrix degradation via TIMPs) have been proposed, however, while these have shown some promise, many target individual catabolic cytokines (e.g., IL-1, TNF), which carries a major shortcoming as many cytokines and other catabolic factors (e.g., NO, PGEs) are produced within a degenerate disc and other cytokines may replace the degenerate effects if one such as IL-1b is removed. 3, 5 One alternative would be to inhibit the intracellular signaling mechanisms common to catabolic processes, however, many of these mechanisms are also deployed by the anabolic factors including growth factors within the disc. Anabolic factors have been proposed as alternative therapeutic strategies to adjust the balance toward matrix synthesis and of these GDF-5/6 (CDMP-1/2) appear to be an attractive growth factor [17] [18] [19] [20] as its receptors are expressed by NP cells even in degenerate discs, however, unlike the majority of the growth factors which have been investigated are not expressed by the blood vessels which are found in degenerate discs. 21 It is important to target anabolic factors which do not have off target effects, such as potential detrimental angiogenesis and accompanied nerve ingrowth which could result from the use of growth factors whose receptors are also expressed by the blood vessels in the IVD.
Thus, identification of intracellular signaling pathways activated by catabolic factors but not anabolic factors is essential to identify potential targets to inhibit degeneration without inhibiting anabolic processes. Recently, p38 MAPK (Mitogen activated protein kinase) 22, 23 and NFkB (Nuclear factor kappa beta) [24] [25] [26] [27] have been identified within IVD cells, as signal transduction pathways following IL-1b stimulation and inhibition of these pathways have shown partial inhibition of the catabolic mediators induced in response to IL-1b. 22, 23 However, importantly these studies were investigated using IVD cells cultured in monolayer culture which do not represent the phenotype of NP cells in vivo, indeed very limited studies have investigated signaling molecule activation in chondrocyte like cells in a 3D culture system which more closely mimics the in vivo phenotype.
This study aimed to identify intracellular signaling pathways differentially expressed between catabolic (IL-1b) and anabolic (GDF-5) factors in human IVDs and determined the activation status of these pathways in native IVD tissues highlighting potential pathways for new therapies.
MATERIALS AND METHODS
Human IVD Samples Human IVD tissue was obtained from surgery for micro discectomy or post-mortem examination (processed within 72 h after death) with informed consent of the patient or relatives. Ethical approval was obtained from Sheffield Research Ethics Committee (09/H1308/70).
Histological Grading
Representative tissue samples were fixed in 10% v/v neutral buffered formalin (Leica, Milton Keynes, UK) and processed to paraffin wax. Haematoxylin and eosin stained sections were evaluated independently by two researchers (AB and CLM) to determine the extent of degenerative tissue changes. Sections were scored numerically between 0 and 12 based on the presence of cell clusters, fissures, loss of demarcation, and haematoxophilia; a score of 0-3 indicates histologically non-degenerate IVDs; !4 indicates evidence of degeneration, as described previously. 6 NP Cell Isolation and Culture Surgical NP tissue samples were finely minced and digested with 2 U/ml protease (Sigma, Poole, UK) in DMEM (Gibco, Paisley, UK) for 30 min at 37˚C, followed by 2 mg/ml collagenase type I (Sigma) in DMEM for 4 h at 37˚C. Cells were maintained in DMEM supplemented with 10% heat inactivated foetal bovine serum (Gibco), 200 U/ml penicillin/200 mg/ml streptomycin (Gibco), 500 ng/ml amphotericin B (Sigma), 2 mM L-glutamine (Gibco), and 50 mg/ml ascorbic acid (Sigma) (complete media). NP cultures were used for experimental purposes upto and including passage 2, note no NP samples which displayed histological evidence of infiltration were used for culture experiments, all cultures were completed with NP cells from individual patients no pooling of patient samples was performed. Cultures were maintained at all times at 37˚C and 5% CO 2 in a humidified environment.
Alginate Culture and Stimulation Regimes
Following expansion in monolayer, NP cells were re-suspended in 1.2% w/v medium viscosity alginic acid (Sigma) in 0.15 M sodium chloride (Fisher Scientific, Loughborough, UK) at a density of 4.0 Â 10 6 cells/ml (which mimics native NP cell density). Alginate beads were formed via extrusion through a 19 gauge needle into 200 mM CaCl 2 (Fisher Scientific), washed in 0.15 M NaCl, and media and maintained in complete media for 14 days prior to IL-1b or GDF-5 stimulation with culture media changed twice weekly. To investigate signaling molecule activation, all treatments were performed with either 10 ng/ml recombinant IL-1b (Peprotech, London, UK), 10 ng/ml recombinant GDF-5 (Peprotech) or left untreated as controls. Stimulations were performed for 30 min prior to downstream analysis (30 min was selected from a preliminary time course experiment where 10, 20, 30, 60, and 180 min were investigated for NFkB activation (data not shown for time course)). Following stimulation alginate beads were dissolved in alginate dissolving buffer (55 mM C 6 H 6 Na 2 O 7 (Sigma); 30 mM EDTA (Fisher); 0.15M NaCl; pH 6.0) for 10 min at 37˚C to release cells for downstream analysis with arrays, immunofluorescence or in cell ELISAs.
R&D Proteome Array for Intracellular Signaling Molecules
NP samples derived from two patients (Grade 6, age 21 and 36) were used for this component of the study (Table S1 ). Forty alginate beads were used for each treatment in duplicate. Following treatment and release from beads, cells were lysed with cell lysis solution containing protease inhibitors, and protein quantified, activation of 46 signaling molecules investigated using the Human Phospho-Kinase Proteome profiler array as per manufactures instructions (Cat: ARY003; R&D systems, Abingdon, UK).
NFkB Immunocytochemistry NP samples derived from three patients (Age 29, 32, 36; Grade 6, 7, 10) were used for this study (Table S1) Cell-Based ELISAs: ERK1/2, p38 MAPK, IkB, c-Jun To confirm results from R&D proteome array on additional patients on key signaling molecules identified to be upregulated by IL-1b, cell-based ELISAs were utilized to investigate quantitative expression of the signaling molecules identified from the array (ERK 1/2, p38 MAPK, c-jun) together with investigating activation of the NFkB signaling pathway which is not included in the array, but demonstrated to be potentially differentially activated via immunofluorescence. This was investigated by determining levels of phosphorylated IkB which is the first stage in the activation of this signaling pathway. The cell-based ELISAs enable quantification of total and phosphorylated proteins in cells in situ without the need to perform protein extraction. A further three patients were utilized for this component of the study (Age 29, 32, 36; Grade 6, 7, 10) (Table S1 ), Alginate beads were transferred one bead per well of four black 96-well microplates (R&D Systems) in complete media (separate plates were used for detection of each signaling molecule). Following stimulations beads were solubilized in alginate dissolving buffer and plates centrifuged for 10 min 400 g to deposit cells on the base of the culture wells, and fixed in 4% v/v formalin/PBS. The amount of phosphorylated ERK1/2, p38 MAPK, c-Jun, or IkB was measured using cell-based ELISA as per manufactures instructions (R&D systems). The plate was read fluorometrically using the Tecan Infinite 200 Pro with excitation at 540 nm and emission at 600 nm, then with excitation at 360 nm and emission at 450 nm. Expression of phosphorylated protein was then assessed between treatment groups.
Immunohistochemical Identification of Activation Status In Vivo
Immunohistochemistry (IHC) was utilized to identify expression levels of phosphorylated-p38 MAPK, phosphorylatedc-jun, and phosphorylated-NFkB in native NP cells from different grades of degeneration to investigate activation status in vivo and whether this altered during degeneration. IHC was utilized rather than western blotting to ensure expression was quantified only within the native NP cells not any infiltrating cells, in addition IHC has the advantage that multiple patient samples can be investigated. Expression of each phosphorylated signaling molecule was investigated in 30 IVD tissue samples (Age: 45.5 AE 14.4) (Table S1 ), divided between three study groups: non-degenerate; histologically graded as intermediate degeneration, and histologically graded as severe degeneration. Briefly, 4 mm paraffin sections were dewaxed, rehydrated, and endogenous peroxidase blocked using hydrogen peroxide. After washing in TBS, sections were subjected to heat induced antigen retrieval (10 min microwave irradiation in 0.05M tris buffer, pH 9.5). Following TBS washing, non-specific binding sites were blocked at room temperature (RT) for 2 h with 10% v/v normal goat serum in 1% w/v BSA/TBS. Sections were incubated overnight at 4˚C with rabbit polyclonal primary antibodies against human phosphorylatedp38 MAPK (1:800; Abcam:ab4822), phosphorylated-c-jun (1:400; Abcam:ab32385), and phosphorylated-NFkB (1:100; Abcam:ab31481). Negative controls in which rabbit IgGs (Abcam) replaced the primary antibody at an equal protein concentration were used. Following TBS washes, sections were incubated in biotinylated goat anti-rabbit antiserum (1:300; Abcam) for 30 min at RT. Disclosure of secondary antibody binding was by HRP-streptavidin-biotin complex (Vector Laboratories, Peterborough, UK) with 0.08% v/v hydrogen peroxide in 0.65 mg/ml 3,3 0 -diaminobenzidine tetrahydrochloride (Sigma) in TBS. Sections were counterstained with Mayer's Haematoxylin (Leica), dehydrated, cleared, and mounted in Pertex (Leica).
All slides were visualized using an Olympus BX60 microscope and images captured using a digital camera and software program QCapture Pro v8. 31 (ENZO, Exeter, UK)) for 1 h prior to stimulation with 10 ng/ml IL-1b for 48 h or left unstimulated to act as signaling inhibitor only controls. All treatments were performed in triplicate on each patient independently.
RNA Extraction, cDNA Synthesis, and Real-time PCR Following stimulation NP cells were recovered from alginate culture and re-suspended in 0.06% w/v type I collagenase and incubated for 10 min at 37˚C and cells recovered by centrifugation. RNA was extracted using Qiagen RNeasy Mini kit (Qiagen, Crawley, UK) as per manufacturers' protocol. cDNA was reverse transcribed using Moloney Murine Leukaemia Virus reverse transcriptase (Bioline) and random hexamers (Applied Biosystems, Warrington, UK). cDNA samples were interrogated by qRT-PCR for the expression of MMP3, MMP13, IL-1b, IL-6, IL-8, and aggrecan (Pre-designed primer/probe mixes Applied Biosystems). Plates were ran on a StepOnePlus real-time PCR machine for 50 cycles (Applied Biosystems). Relative gene expression levels were calculated using the 2 ÀDDCT method and normalized against two internal reference genes (GAPDH and 18S) and un-stimulated control samples. Stable expression of internal reference genes was confirmed by geNorm algorithm.
Statistical Analysis
All data from this study was shown to be non-parametric and as such statistical analysis for assays was performed using the Kruskal-Wallis test with Conover-Ingman post hoc tests used to investigate significant differences between treatment groups or grades of degeneration. All statistical analysis was performed using statistical software: Stats-Direct. 
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(c-jun, ERK1/2, and p38) (Fig. 1, Table 1 ) and two following stimulation with GDF-5 (STAT1 and 4) (p < 0.05) ( Table 1) . Interestingly, IL-1b stimulation resulted in the significant down regulation of 12 signaling proteins: including STATs (STAT3, 5A/B, and 6); src family members (src, YES, Fyn, Hck, Lck); and other signaling proteins involved in focal adhesions (FAK, Paxillin) ( Table 1 ). In addition, decreased activation of MEK1/2 and mTOR was observed (p < 0.05) ( Table 1) . While GDF-5 only significantly inhibited one signaling protein (Lck) (p < 0.05) ( Table 1) . Of particular interest, pERK1/2 was increased following GDF-5 (6-fold) and IL1b (30-fold) stimulation although only significantly so following IL-1b (p < 0.05) ( Table 1 , Fig. 1 ), while FAK was down regulated by both GDF-5 and IL-1b although again only significantly so following IL-1b stimulation (p < 0.05) (Table 1, Fig. 1) . Surprisingly, from the 46 signaling proteins investigated only three were shown to be differentially activated by IL-1b but not GDF-5, these were p38 MAPK, JNK, and its downstream target c-jun (p < 0.05) ( Table 1 , Fig. 1 ). Caution should be taken when utilizing these results as they were completed on two patients each in quadruplet, thus, the biological significance cannot be concluded from this component of the study. Hence, this component of the study was utilized to identify potential signaling pathways for further investigation in additional patient samples.
As the proteome profiler array did not include NFkB signaling this was investigated initially using immunofluorescence using a phosphorylated antibody which would only detect activated NFkB. NP cells cultured in alginate to maintain NP cell phenotype were stimulated with IL-1b or GDF-5. Cells which were unstimulated or stimulated with GDF-5 showed punctate staining only, while cells stimulated with IL-1b showed increased staining across the cell, including nuclear staining, suggesting activation of the NFkB pathway was more pronounced with IL-1b stimulation (Fig. 2) . Cell-based ELISAs were then utilized to confirm the results from profiler and immunofluorescence on further patient samples. Phosphorylated ERK 1/2 was significantly increased following GDF-5 and IL-1b stimulation although induction was significantly more following IL-1b stimulation (p < 0.05) (Fig. 3A) . GDF-5 stimulation had no stimulatory effect on the phosphorylation status of p38 MAPK, c-jun or IkB, although a significant decrease was seen in phosphorylated c-jun (p < 0.05) (Fig. 3) , however, IL-1b stimulation induced phosphorylation of p38 MAPK, c-jun and IkB, which was significant for p38 MAPK and c-jun (p < 0.05) (Fig. 3B-D) .
Activation Status of IL-1b Induced Intracellular Signaling Pathways In Vivo
To determine whether IL-1b induced signaling pathways: p38 MAPK, c-jun, and NFkB are active within human IVDs and whether these are differentially activated within degenerate discs, human IVDs from differing grades of histological degeneration were investigated for IHC staining with phosphor specific antibodies. Cytoplasmic staining for phospho-p38 MAPK, c-jun, and NFkB were identified in NP cells, particularly those cells in clusters (Fig. 4) . Percentage immunopositive cells for phosphorylated p38 MAPK and phosphorylated NFkB were significantly increased in discs with intermediate histological degeneration compared to histologically non-degenerate discs (p < 0.05) (Fig. 4) . While percentage immunopositive cells for phosphorylated c-jun was significantly higher in both high grade and intermediate grades of histological degeneration compared to histologically nondegenerate discs (p < 0.05) (Fig. 4) .
Effects of Inhibitors of Intracellular Signaling on Native mRNA Expression in NP Cells
Inhibition of p38 MAPK signaling decreased mRNA expression of MMP3, MMP13, IL-1b, and IL-8 but not IL-6 in cells not stimulated with IL-1b although this only reached significance for MMP3 and IL-1b (p < 0.05) (Fig. 5) . Inhibition of JNK or its downstream target c-jun in the absence of IL-1b resulted in significant decrease in native mRNA expression of IL-1b (p < 0.05) (Fig. 5) , while only c-jun inhibition decreased native expression of MMP3, and JNK inhibition decreased native expression of IL-8 (p < 0.05) (Fig. 5) , conversely native IL-6 mRNA expression was increased by inhibition of JNK, or c-jun (p < 0.05) (Fig. 5) . Inhibition of NFkB signaling significantly decreased mRNA expression of MMP13 (p < 0.05) (Fig. 5 ) in the absence of IL-1.
Inhibition of IL-1b Actions Via Inhibition of Intracellular Signaling
Real-time PCR was utilized to investigate effects of signaling inhibitors on IL-1b actions. IL-1b stimulation of NP cells significantly increased mRNA expression of MMP3, MMP13, IL-1b, IL-6, and IL-8 (p < 0.05) (Fig. 5) . IL-1b stimulation of NP cells in the presence of a p38 MAPK inhibitor induced MMP3, IL-6, and IL-8 mRNA although to a lesser extent than IL-1b alone (p < 0.05) (Fig. 5) , while p38 MAPK inhibition prevented stimulation of MMP13 mRNA by IL-1b but had no effect on the induction of IL-1b mRNA by IL-1b (Fig. 5) .
IL-1b stimulation of NP cells in the presence of a c-jun inhibitor induced MMP3, MMP13, and IL-1b mRNA although to a lesser extent than IL-1b alone (p < 0.05) (Fig. 5) , while c-jun inhibition had no effect on IL-6 or IL-8 mRNA induction by IL-1b (Fig. 5) . IL-1b stimulation of NP cells in the presence of a JNK inhibitor induced MMP3, IL-1b, and IL-8 mRNA although to a lesser extent than IL-1b alone (p < 0.05) (Fig. 5 ), while JNK inhibition had no effect on MMP13 or IL-6 mRNA induction by IL-1b (Fig. 5) .
IL-1b stimulation of NP cells in the presence of an inhibitor of NFkB signaling inhibited the IL-1b induced mRNA expression of MMP3, MMP13, IL-1b, IL-6, and IL-8 mRNA expression (p < 0.05) (Fig. 5) .
Effect of Signaling Inhibitors on Aggrecan mRNA Expression
In order to determine the effect of signaling inhibitors on normal anabolic mRNA expression the expression of aggrecan was investigated following inhibition of signaling factors. Inhibition of JNK or c-jun had no effect on mRNA expression of aggrecan, however, inhibition of p38 MAPK or NFkB resulted in down regulation of mRNA for aggrecan although this failed to reach significance (p > 0.05) (Fig. S1) .
DISCUSSION
This study aimed to investigate the intracellular signaling pathways activated by IL-1b in the degenerate IVD which were not activated by the anabolic factor GDF-5 to identify potential targets for new therapeutic strategies. It is important to identify signaling pathways which are not activated by anabolic factors such as GDF-5 to ensure native growth factors are not inhibited, while inhibiting catabolic processes.
Initial studies utilized the proteasome arrays to screen 46 signaling molecules to investigate activation of a wide range of signaling molecules and determine if these signaling molecules were differentially induced by IL-1b and not by the anabolic factor GDF-5. Interestingly, only a limited number of signaling molecules were activated by IL-1b in these cells and of these ERK1/2 was also induced by GDF-5, while p38, JNK, and c-jun were induced significantly more by IL-1b than GDF-5, while this component of the study was completed on two patients. These results were further confirmed in additional patients using cell-based ELISAs. IL-1b has been previously shown to induce expression of phosphorylated-ERK, p38, and JNK in human IVD cells in monolayer culture, 32 and together with NFkB signaling in rat NP cells. 33 Furthermore as NFkB signaling was not included within the array, but previous studies have demonstrated this is a key signaling pathway activated by IL-1b in IVD cells, [24] [25] [26] [27] this was investigated within human NP cells cultured in alginate to maintain phenotype which demonstrated activation by IL-1b but not GDF-5, which was demonstrated using immunofluorescence and confirmed by cell-based ELISAs. Unfortunately performing these experimental procedures in alginate beads to maintain the phenotype of the NP cells, alginate was shown to have high auto-fluorescence within immunofluorescence experiments which prevented quantification of this data; however, the use of cell-based ELISAs confirmed activation of the NFkB signaling pathway. GDF-5 stimulation resulted in activation of STAT1 and 4 which has not been previously demonstrated, however, STAT1 has been shown to be involved in the signaling of other growth factors in chondrocytes, and has been shown to be a key signaling molecule in FGF signaling, 34 and IGFBP-3 signaling. 35 Interestingly, IL-1b stimulation resulted in the down regulation of 12 signaling proteins: including STATs (STAT3, 5A/B, and 6), STAT3 has been shown to be expressed by human NP cells previously, 36 STAT3 is associated with IL-6 signaling in chondrocytes where it has been shown to induce expression of cartilage matrix genes. 37 These anabolic effects of IL-6 were inhibited by STAT3 knockdown. 37 Thus, the down regulation of STAT3 by IL-1b seen in the current study could be linked to the effects of IL-1 on matrix gene expression, however, its role in the IVD is poorly understood and requires further investigation.
The combined down regulation of the src family proteins, FAK and Paxillin demonstrate a potential role for IL-1b in the disruption of focal adhesion signaling, src family protein kinases phosphorylate FAK and if these are inhibited integrin regulated adhesion to the extracellular matrix is disrupted. 38 Thus the inhibition of src family, FAK and paxillin signaling could explain the altered integrin signaling seen during disc degeneration. 39 mTOR is a key signaling pathway involved in autophagy, inhibition of the mTOR complex has been demonstrated to induce autophagy, 40 thus, the inhibition of mTOR shown here by IL-1b could provide a role for IL-1b induced autophagy in the IVD. 40 Additionally mTOR is involved in regulation of cellular senescence and inhibitors of mTOR have been shown to induce cellular senescence, 40 which is also a key feature of disc degeneration. 41 As such the modulation of these signaling pathways by IL-1b requires further investigation particularly whether abrogating the inhibition can be targeted by potential therapies.
It should be noted that activation of these signaling molecules reported within this study were completed following 30 min, which was shown to be optimal from initial preliminary studies, it was not possible to complete all studies at multiple time points but it should be considered that as arrays investigated a wide range of signaling molecules further factors may be activated by these factors at alternative times, however, the majority of studies investigating signaling factors do so over short time periods such as 30 min.
Following the identification of p38, c-jun, and NFkB signaling as potentially differentially induced by IL-1b, expression of phosphorylated forms of these proteins was determined in native human IVDs, which demonstrated all three signaling proteins were active within native NP cells with increased expression of phosphorylated-p38, c-jun, and NFkB in discs with intermediate grades of histological degeneration compared to those discs graded as non-degenerate, while c-jun was also increased in discs with severe histological degeneration. Interestingly, the discs with highest levels of expression are also those which have previously been shown to express highest levels of IL-1b, that is, discs with intermediate grades of degeneration. 6 Tolonen et al. previously investigated protein expression of c-jun in human IVD samples and demonstrated expression in 74% of patient samples investigated, 42 unfortunately it is not clear whether they utilized a phospho-specific antibody and they did not investigate whether expression altered during degeneration, however, in agreement with the current study expression was seen within NP cell clusters. 42 Interestingly, in stab induced degeneration in rat IVDs an induction of p-ERK and p-p38 was observed associated with increased immunopositivitiy for IL-1b and IL-6, in contrast no increase in p-JNK was observed. 43 Nerlich et al. also demonstrated increased activation of NFkB signaling in human IVDs which increased with age and grade of degeneration. 44 Increased NFkB signaling with degeneration has been further confirmed recently. 45 Together this data supports the potential role of inhibitors of these signaling pathways in IVD degeneration.
Thus, this study went on to investigate the potential use of inhibitors of these signaling pathways within human NP cells derived from degenerate discs on a number of key targets which have been shown previously to be regulated by IL-1b. Interestingly, inhibitors of p38 signaling and the JNK/c-jun pathway only partially abrogated effects of IL-1b suggesting these factors alone may not be sufficient to inhibit the plethora of effects induced by IL-1b (Fig. S2) . Klawitter et al. demonstrated partial inhibition of IL-1b effects via curcuma and curcumin with inhibition of IL-1b induced expression of MMPs and IL-6 but failed to inhibit effects on IL-1b, IL-8, and TNF expression, these effects were shown to be a result of JNK inhibition, 32 while other studies have suggested curcumins actions are via inhibition of NFkB signaling. 25 25 both studies associating actions to inhibition of the NFkB pathway. Inhibition of p38 signaling in rabbit NP cells abrogated the effects of IL-1 on inhibition of matrix synthesis and partly reduced the effects on expression of Cox-2, MMP3, IL-1 and IL-6, 23 and PGE 2 22 which agrees with the current study.
However, inhibition of the NFkB signaling pathway demonstrated the most potential in the current study with abrogation of all the effects of IL-1b investigated. Wang et al. also found that NFkB inhibition could completely abrogate IL-1b induced MMP3, while inhibition of p38/ERK/JNK only partially abrogated the effects of IL-1b. 28 In contrast, IL-1b induced expression of ADAMTS4 could be blocked by inhibitors of NFkB, p38, JNK, and ERK1 signaling, 33 recently Sun et al. further demonstrated the important role for NFkB signaling in the IL-1b induced expression of ADAMTS. 24, 45 Inhibition of NFkB signaling has been shown to abrogate a wide range of IL-1 induced effects, demonstrating the potential of this signaling target for inhibiting the plethora of IL-1 effects in the IVD. 26 The potential role of NFkB as a target for treating disc degeneration is further supported by the finding that NFkB signaling was increased in an accelerated aging mouse model, and catabolic effects could be blocked by inhibiting NFkB. 48 However, the current study demonstrated inhibition of the NFkB signaling did induce a baseline decrease in the expression of aggrecan mRNA expression, which although failed to reach significance should be treated with caution.
CONCLUSION
This study has highlighted three key pathways were identified which were differentially activated by IL-1b but not GDF-5; namely p38, c-jun, and NFkB. All pathways were shown to be activated during human IVD degeneration and inhibition of these pathways reduced or abrogated the catabolic effects of IL-1b, with inhibition of NFkB signaling demonstrating more widespread inhibition of IL-1 effects and thus potentially holds most promise for future investigations (Fig. S2) .
